Uromitexan, Injektions-/Infusionslösung

7680434070317 CH-43407 Ampullen
Uromitexan, Injektions-/Infusionslösung
Uromitexan, Injektions-/Infusionslösung
Uromitexan, Injektions-/Infusionslösung
1 / 3
google

Article details

Package size
15
Selling units
15
Measure
Ampulle(n)
Galenic form
Ampullen
Galenic group
unbekannt

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Summary of Product Characteristics
Allemand
15/11/2023
Summary of Product Characteristics
Français
15/11/2023
Summary of Product Characteristics
Italien
15/11/2023

Detailed composition

Substance Quantity Type Category
(N/A)
400.0 MG Substance Wirkstoff (Principe actif)
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HBESI

Reimbursement information

Public price
CHF 78.90
Specialties list
Yes
Generic
No

Reimbursement limitation

SL addition date: 15/03/1982

Authorization holder

Baxter AG

8152 Opfikon

Authorization information

Swissmedic authorization number
43407
Drug name
Uromitexan, Injektions-/Infusionslösung
Galenic form
LSIN
ATC Code
V03AF01
Authorization status
Z
Dispensing category
B
First authorization
31/03/1981
Authorization expiration date
31/12/9999
IT Number
05.99.0.
Domain
Human medicine
Field of application
Verhütung der Urotoxizität von Oxazaphosphorinen

Package details

Description (FR)
UROMITEXAN sol inj 400 mg/4ml 15 amp 4 ml
Description (DE)
UROMITEXAN Inj Lös 400 mg/4ml 15 Amp 4 ml
Market launch
31/03/1981
Narcotic (BTM)
No